Biogen has signed over development and launch responsibilities for an experimental lymphoma drug to partner Roche, reworking part of a longstanding collaboration between the two companies that’s produced the antibody drugs Rituxan, Ocrevus and Gazyva.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,